Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation by Xuemei Luo, Jose Chaves, Amol D. Dhamane, Feng Dai, Dominick Latremouille-Viau, Aolin Wang

Get full text

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding. by Alexander T Cohen, Janvi Sah, Amol D Dhamane, Theodore Lee, Lisa Rosenblatt, Patrick Hlavacek, Birol Emir, Allison Keshishian, Huseyin Yuce, Xuemei Luo

Get full text

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients by Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y. H. Lip

Get full text

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study by Steve Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Xiaoyan Li, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Manuela Di Fusco, Alessandra B. Garcia Reeves, Huseyin Yuce, Gregory Y. H. Lip

Get full text

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants by Christine L. Baker JD, MPH, Amol D. Dhamane BPharm, MS, Jigar Rajpura PhD, Jack Mardekian PhD, Oluwaseyi Dina MPH, Cristina Russ MD, PhD, Lisa Rosenblatt MD, MPH, Melissa Lingohr-Smith PhD, Jay Lin PhD, MBA

Get full text